Refractory pityriasis rubra pilaris treated with abrocitinib

Abstract

Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts the quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic therapies failed.

Keywords

• Pityriasis rubra pilaris
• Janus kinase (JAK)
• abrocitinib